Related Experiment Video

Updated: Apr 7, 2026

Differential Effects of Lipid-lowering Drugs in Modulating Morphology of Cholesterol Particles
09:15

Differential Effects of Lipid-lowering Drugs in Modulating Morphology of Cholesterol Particles

Published on: November 10, 2017

15.2K

Statin-induced coronary artery disease regression rates differ in men and women

Rishi Puri1, Steven E Nissen, Stephen J Nicholls

  • 1aDepartment of Cardiovascular Medicine, C5Research (C5R), Cleveland Clinic, Cleveland, Ohio, USA bSouth Australian Health and Medical Research Institute, University of Adelaide, Adelaide, Australia.

Current Opinion in Lipidology
|July 2, 2015
PubMed

Insights

High-intensity statin therapy shows greater coronary atheroma regression in women than men. This suggests personalized treatment strategies for atherosclerotic disease may benefit women more, supporting broad statin use in this population.

Area of Science:

  • Cardiovascular Medicine
  • Pharmacology
  • Medical Imaging

Background:

  • The efficacy of statins in women versus men remains debated.
  • Recent characterization of high-intensity statin therapy's antiatherosclerotic effects in women is emerging.
  • This review synthesizes evidence on sex-based differences in statin efficacy.

Purpose of the Study:

  • To review recent evidence on the antiatherosclerotic effects of high-intensity statins in women compared to men.
  • To summarize findings regarding sex-based differences in coronary atheroma regression.

Main Methods:

  • Utilized coronary intravascular ultrasound (IVUS) for plaque imaging.
  • Analyzed data from a randomized controlled trial comparing rosuvastatin and atorvastatin.
  • Evaluated antiatherosclerotic efficacy over a 24-month period.

Main Results:

  • Significantly greater coronary atheroma regression was observed in women compared to men.
  • Lower achieved low-density lipoprotein (LDL) cholesterol levels correlated with greater regression in women.
  • A significant interaction between sex and statin type was identified.

Conclusions:

  • Findings support the widespread use of high-intensity statins in women with coronary artery disease.
  • Women may experience greater benefits from statin therapy than men.
  • Dedicated clinical trials for women are needed to refine personalized therapeutic strategies for atherosclerosis.
Abstract

More Related Videos

LDL Cholesterol Uptake Assay Using Live Cell Imaging Analysis with Cell Health Monitoring08:45

LDL Cholesterol Uptake Assay Using Live Cell Imaging Analysis with Cell Health Monitoring

Published on: November 17, 2018

14.3K

Related Concept Videos

Lipid-Lowering Drugs: Statins and Miscellaneous Agents01:20

Lipid-Lowering Drugs: Statins and Miscellaneous Agents

Hyperlipidemia, a medical condition often referred to as high cholesterol, is characterized by abnormally elevated levels of lipids in the bloodstream. When present in excess, these lipids, specifically cholesterol and triglycerides, can lead to serious health complications, often involving cardiovascular diseases. Illnesses like atherosclerosis, heart attacks, and pancreatitis have all been linked to untreated hyperlipidemia. This means controlling and regulating cholesterol and triglyceride...
1.8K
Coronary Artery Disease IV: Preventive Measures01:26

Coronary Artery Disease IV: Preventive Measures

Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
861
Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
592
Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
419
Angina IV: Management01:26

Angina IV: Management

IntroductionThe management of angina requires a comprehensive approach that includes pharmacological therapies, medical procedures, and lifestyle modifications.Pharmacological TherapiesAntiplatelet agents, such as aspirin, clopidogrel, prasugrel, and ticagrelor, play a pivotal role in preventing thrombus formation in patients with angina. These medications inhibit platelet aggregation and reduce the likelihood of myocardial infarction and other cardiovascular events.Anticoagulants, including...
429
Antianginal Drugs: Calcium Channel Blockers and Ranolazine01:25

Antianginal Drugs: Calcium Channel Blockers and Ranolazine

Angina pectoris, a primary symptom of ischemic heart disease, requires careful pharmacological interventions. In this context, calcium channel blockers (CCBs) and ranolazine have emerged as crucial pharmacotherapeutic agents, providing deep insights into the complexities of angina management.
CCBs, a diverse class that includes dihydropyridines (nifedipine) and diphenylalkylamines (verapamil and diltiazem), exert their effect by blocking calcium channels in cardiac and smooth muscle cells. This...
1.8K